Adalimumab 00074-1117
Product NDC
00074-1117- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- September 27, 2021
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab | 80 mg/.8mL |
Packaging Options(1)
.8 mL in 1 SYRINGE (0074-1117-00)